Representation of Arcturus Therapeutics in a merger with Alcobra
Our firm represented Arcturus Therapeutics, Inc. in an agreement to merge with Alcobra Ltd. (NASDAQ: ADHD). For more information, click here.
Our firm represented Arcturus Therapeutics, Inc. in an agreement to merge with Alcobra Ltd. (NASDAQ: ADHD). For more information, click here.
Another successful funding round for an automotive company! Our firm represented Innoviz Technologies, a developer of LiDAR sensors, in a $65 million funding round. For more information, click here.
Our firm represented Oryx Vision, an autonomous car depth sensor developer, in a $50 million funding round. For more information, click here.
Our firm represented EMK Capital in the acquisition of Luminati, the enterprise proxy network division of Hola Networks. For more information, click here.
Our firm represented SK Capital in the acquisition of Perrigos (NYSE; TASE: PRGO) API division. For more information, click here.
Representation of Mapi Pharma, an Israeli clinical stage pharmaceutical company, in a $10 million investment round. For more information, click here.
Representation of Intec Pharma (NASDAQ and TASE: NTEC), in a $57.5 million public offering. For more information, click here.